Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Research In Brief

This article was originally published in The Gray Sheet

Executive Summary

Medtronic lead integrity alert: An algorithm to detect transient pace-sense conductor fractures in Medtronic's Sprint Fidelis implantable cardioverter defibrillator "appears to forewarn most patients ... before inappropriate shocks are delivered," according to an article in the August issue of HeartRhythm. The study, which included all patients at the Minneapolis Heart Institute implanted with Sprint Fidelis leads and Medtronic ICD pulse generators, found that 52 of 461 leads failed between October 2004 and January 2010. Inappropriate shocks were the first sign of lead failure in 69% of the 26 patients whose devices did not have the lead integrity alert capability, versus 17% of the 23 patients who did. Medtronic added the feature, which allows defibrillators to make an audible tone when they detect a potential fracture, in 2008 (1"The Gray Sheet" Sept. 8, 2008). But 32% of patients whose audible alerts were triggered did not immediately hear the tone, the study found

You may also be interested in...



Medtronic Fidelis update

Failure rate for Medtronic's Fidelis ICD lead is 4.8% (+2.1 or -3.6) at 39 months, according to data from the firm's System Longevity Study, and 3.5% (+0.6 or -0.6) according to data from its CareLink remote monitoring network, the company reports Aug. 29. Medtronic recalled the size 7 French lead in October 2007 when the System Longevity Study and CareLink network showed the 30-month failure rate was 2.3%. By contrast, the failure rate for Medtronic's Quattro lead is 0.9% (1"The Gray Sheet" Oct. 22, 2007, p. 3). Separately, on Sept. 4, FDA approved an update to the software Medtronic is using to track Fidelis lead fractures called the Lead Integrity Alert. The feature allows defibrillators to make an audible tone when it detects a possible lead fracture

Coronavirus Update: UK Calls For COVID-19 Patients To Join Trials

GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.

Manpower Not Materials Could Hold German COVID-19 Testing Back

Lab testing for COVID-19 has risen to a new high of 314,000 tests per week in Germany, where the concerns are perhaps less about test availability than staff numbers to oversee the testing protocols.

Topics

UsernamePublicRestriction

Register

MT029208

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel